The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50

Digestive and Liver Disease

Volumn 49, Issue 5, 2017, Pages 557-561

  Kim, Nam Hee ^a   Park, Jung Ho ^a   Park, Dong Il ^a   Sohn, Chong Il ^a   Choi, Kyuyong ^a   Jung, Yoon Suk ^a  

^a School of Medicine   (South Korea)

Author keywords

Advanced colorectal neoplasia; Fecal immunochemical test; Young population

Indexed keywords

HEMOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER TEST; CLINICAL EVALUATION; COLONOSCOPE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY ANALYZER; IMMUNOLOGICAL PROCEDURES; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBE; AGE DISTRIBUTION; CHEMISTRY; EARLY CANCER DIAGNOSIS; IMMUNOLOGY; OCCULT BLOOD; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SOUTH KOREA;

ADULT; AGE DISTRIBUTION; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; ROC CURVE;

EID: 85008450539     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.12.020     Document Type: Article

References (30)

1. [1] Ferlay, J., Shin, H.R., Bray, F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127 (2010), 2893–2917.
2. [2] Inra, J.A., Syngal, S., Colorectal cancer in young adults. Digestive Diseases and Sciences 60 (2015), 722–733.
3. [3] Song, Y.K., Park, Y.S., Seon, C.S., et al. Alcohol drinking increased the risk of advanced colorectal adenomas. Intestinal Research 13 (2015), 74–79.
4. [4] Carroll, M.R., Seaman, H.E., Halloran, S.P., Tests and investigations for colorectal cancer screening. Clinical Biochemistry 47 (2014), 921–939.
5. [5] Allison, J.E., Fraser, C.G., Halloran, S.P., et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut and Liver 8 (2014), 117–130.
6. [6] Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-society Task Force on colorectal cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570–1595.
7. [7] Young, G.P., Symonds, E.L., Allison, J.E., et al. Advances in fecal occult blood tests: the FIT revolution. Digestive Diseases and Sciences 60 (2015), 609–622.
8. [8] Quintero, E., Castells, A., Bujanda, L., et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. The New England Journal of Medicine 366 (2012), 697–706.
9. [9] Rex, D.K., Johnson, D.A., Anderson, J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. The American Journal of Gastroenterology 104 (2009), 739–750.
10. [10] Lee, B.I., Hong, S.P., Kim, S.E., et al. Korean guidelines for colorectal cancer screening and polyp detection. Clinical Endoscopy 45 (2012), 25–43.
11. [11] Centers for Disease Control and Prevention, Vital signs: colorectal cancer screening, incidence, and mortality—United States, 2002–2010. MMWR Morbidity and Mortality Weekly Report 60 (2011), 884–889.
12. [12] Fairley, T.L., Cardinez, C.J., Martin, J., et al. Colorectal cancer in U S. adults younger than 50 years of age, 1998–2001. Cancer 107 (2006), 1153–1161.
13. [13] O'Connell, J.B., Maggard, M.A., Liu, J.H., et al. Rates of colon and rectal cancers are increasing in young adults. The American Surgeon 69 (2003), 866–872.
14. [14] Bailey, C.E., Hu, C., You, Y.N., et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surgery 150 (2015), 17–22.
15. [15] Marble, K., Banerjee, S., Greenwald, L., Colorectal carcinoma in young patients. Journal of Surgical Oncology 51 (1992), 179–182.
16. [16] Chiang, J., Chen, M., Changchien, C.R., et al. Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Diseases of the Colon and Rectum 46 (2003), 904–910.
17. [17] Choe, J.W., Chang, H.S., Yang, S.K., et al. Screening colonoscopy in asymptomatic average-risk Koreans: analysis in relation to age and sex. Journal of Gastroenterology and Hepatology 22 (2007), 1003–1008.
18. [18] Regula, J., Rupinski, M., Kraszewska, E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. The New England Journal of Medicine 355 (2006), 1863–1872.
19. [19] Botteri, E., Iodice, S., Bagnardi, V., et al. Smoking and colorectal cancer: a meta-analysis. JAMA 300 (2008), 2765–2778.
20. [20] Okabayashi, K., Ashrafian, H., Hasegawa, H., et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. The American Journal of Gastroenterology 107 (2012), 1175–1185 quiz 86.
21. [21] Jinjuvadia, R., Lohia, P., Jinjuvadia, C., et al. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. Journal of Clinical Gastroenterology 47 (2013), 33–44.
22. [22] Jung, Y.S., Ryu, S., Chang, Y., et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointestinal Endoscopy 81 (2015), 637–645 e7.
23. [23] Hong, S.N., Kim, J.H., Choe, W.H., et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointestinal Endoscopy 72 (2010), 480–489.
24. [24] Chang, L.C., Wu, M.S., Tu, C.H., et al. Metabolic syndrome and smoking may justify earlier colorectal cancer screening in men. Gastrointestinal Endoscopy 79 (2014), 961–969.
25. [25] Chung, S.J., Kim, Y.S., Yang, S.Y., et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy. Journal of Gastroenterology and Hepatology 25 (2010), 519–525.
26. [26] Soweid, A.M., Kobeissy, A.A., Jamali, F.R., et al. A randomized single-blind trial of standard diet versus fiber-free diet with polyethylene glycol electrolyte solution for colonoscopy preparation. Endoscopy 42 (2010), 633–638.
27. [27] Fraser, C.G., Allison, J.E., Halloran, S.P., et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. Journal of the National Cancer Institute 104 (2012), 810–814.
28. [28] Wen, C.P., David Cheng, T.Y., Tsai, S.P., et al. Are Asians at greater mortality risks for being overweight than Caucasians: redefining obesity for Asians. Public Health Nutrition 12 (2009), 497–506.
29. [29] Lieberman, D.A., Rex, D.K., Winawer, S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-society Task Force on colorectal cancer. Gastroenterology 143 (2012), 844–857.
30. [30] Chen, Y.-Y., Chen, T.-H., Su, M.-Y., et al. Accuracy of immunochemical fecal occult blood test for detecting colorectal neoplasms in individuals undergoing health check-ups. Advances in Digestive Medicine 1 (2014), 74–79.